CompletedPhase 3NCT04318015

Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Respiratory Diseases, Mexico
Principal Investigator
Jorge Rojas-Serrano, MD, PhD.
National Institute of Respiratory Diseases - México
Intervention
Hydroxychloroquine(drug)
Enrollment
289 target
Eligibility
18 years · All sexes
Timeline
20202021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04318015 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials